Stock Markets March 17, 2026

Brussels Stocks Close Higher as BEL 20 Advances 0.74%

Utilities, basic materials and healthcare shares lead gains as market breadth favours advancers

By Sofia Navarro
Brussels Stocks Close Higher as BEL 20 Advances 0.74%

Belgian equities finished the trading session higher, with the BEL 20 index rising 0.74%. Gains were concentrated in the Utilities, Basic Materials and Healthcare sectors. Market breadth favoured advancing stocks by 55 to 41, and 12 issues ended unchanged. Key commodities and currency benchmarks showed mixed moves at the close.

Key Points

  • BEL 20 index closed up 0.74% in Brussels, driven by Utilities, Basic Materials and Healthcare sectors.
  • Top session performers were Umicore SA (EBR:UMI), Elia (EBR:ELI) and Azelis Corporate Services NV (EBR:AZE); top decliners included Melexis NV (EBR:MLXS), Montea C.V.A. (EBR:MONTE) and Ackermans & Van Haaren NV (EBR:ACKB).
  • Commodities and FX showed mixed moves: gold futures rose, both crude and Brent oil contracts gained, EUR/USD and EUR/GBP were effectively unchanged, and the US Dollar Index Futures slipped.

Belgian equities ended the session in positive territory on Tuesday, with the benchmark BEL 20 index closing up 0.74% in Brussels. Strength in the Utilities, Basic Materials and Healthcare sectors helped drive the advance.

Among constituents, Umicore SA (EBR:UMI) recorded the strongest gain on the index, climbing 3.81% - a rise of 0.62 points - to finish at 16.88. Elia (EBR:ELI) also contributed to the upside, adding 2.94% or 3.90 points to close at 136.70. Azelis Corporate Services NV (EBR:AZE) rose 2.11%, an increase of 0.16 points, to end the day at 7.51.

On the downside, Melexis NV (EBR:MLXS) was the weakest performer among the listed names, slipping 0.84% or 0.45 points to close at 53.05. Montea C.V.A. (EBR:MONTE) declined 0.43%, down 0.30 points, to finish at 69.90, while Ackermans & Van Haaren NV (EBR:ACKB) fell 0.37% or 1.00 points to end the session at 266.60.

Market breadth on the Brussels Stock Exchange favoured advancers, with 55 stocks rising versus 41 that fell; 12 issues were unchanged at the close.

Commodities saw mixed action. Gold futures for April delivery were up 0.15%, gaining 7.51 to trade at 5,009.71 a troy ounce. In energy markets, crude oil for May delivery rose 2.51% or 2.32 to $94.78 a barrel, while the May Brent contract gained 2.34% or 2.34 to trade at $102.55 a barrel.

In foreign exchange, EUR/USD was unchanged 0.21% to 1.15, while EUR/GBP was unchanged 0.01% to 0.86. The US Dollar Index Futures moved lower, down 0.10% at 99.36.


Summary of moves

  • BEL 20 closed higher by 0.74%.
  • Top gainers included Umicore, Elia and Azelis.
  • Melexis, Montea and Ackermans & Van Haaren were among the laggards.

Context and note on investment tools

Investors often seek better data and analytical tools to identify opportunities. Questions about the best investments in 2026 and the role of institutional-grade data and AI-powered insights are increasingly part of market conversations, as market participants look for ways to improve decision-making without assuming guaranteed outcomes.

Risks

  • Sector concentration risk - Gains were led by a few sectors (Utilities, Basic Materials, Healthcare), which could leave the market sensitive to sector-specific news.
  • Commodity price volatility - Movements in oil and gold prices may influence corporate costs and investor sentiment across materials and energy-related firms.
  • Currency fluctuations - Relative stability in EUR/USD and EUR/GBP reported at close could change, potentially affecting multinational companies and export-sensitive sectors.

More from Stock Markets

Jassy Says AI Could Propel AWS to $600 Billion in Annual Revenue Mar 17, 2026 Jassy Says AI Could Propel AWS to $600 Billion in Annual Revenue by 2036 Mar 17, 2026 Freshpet Shares Drop After Advertising Claims Deemed Misleading by NAD Mar 17, 2026 Senator Seeks White House Clarification on $10 Billion Payment Linked to TikTok U.S. Deal Mar 17, 2026 Appeals Court Revives Whistleblower Suit Alleging Drugmakers Overcharged Safety-Net Programs Mar 17, 2026